Flavonoids as Promising Drugs for Concomitant Therapy during Long-Term Therapy of Drug-Resistant Tuberculosis
The review analyzed 56 publications in order to investigate the possibility of using flavonoids as concomitant therapy in the long-term treatment of multidrug-resistant tuberculosis (MDR TB) and to determine the relevance of such studies. Publications were selected from main databases including RSCI, PubMed, and Google Scholar. The use of bioflavonoids in tuberculosis chemotherapy can enhance its effectiveness and prevent toxic effects of anti-tuberculosis drugs. The growing rate of MDR TB among new tuberculosis cases confirms the relevance in this study.
Authors
- D.А. Kudlаy (ORCID: https://orcid.org/0000-0003-1878-4467)
- А. В. Полуконова (ORCID: https://orcid.org/0000-0001-7198-1254)
- Н. В. Полуконова (ORCID: https://orcid.org/0000-0001-9228-6808)
- Galina N. Maslyakova (ORCID: https://orcid.org/0000-0001-8834-1536)
- Nikita Navolokin (ORCID: https://orcid.org/0000-0001-7876-9758)
- Alla B. Bucharskaya (ORCID: https://orcid.org/0000-0003-0503-6486)
- Т. И. Морозова (ORCID: https://orcid.org/0000-0002-9960-348X)
Institutions
- Sechenov University (RU)
- Saratov State Medical University (RU)
Publication Details
- Journal
- Tuberculosis and lung diseases
- Published
- 2025-09-12
- DOI
- https://doi.org/10.58838/2075-1230-2025-103-4-100-108
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Directorate for Biological Sciences